Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size

American Journal of Respiratory and Critical Care Medicine

Volumn 170, Issue 4, 2004, Pages 377-382

  Maskell, Nick A ^a   Lee, Y C Gary ^a   Gleeson, Fergus V ^a   Hedley, Emma L ^a   Pengelly, Gerry ^a   Davies, Robert J O ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Acute respiratory distress syndrome; Pleural effusion; Pleurodesis; Randomized trial; Talc

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 8; TALC; TETRACYCLINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FEVER; GAS EXCHANGE; HUMAN; HYPOXEMIA; LUNG ALVEOLUS OXYGEN TENSION; LUNG CLEARANCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OXYGEN SATURATION; PARTICLE SIZE; PLEURA EFFUSION; PLEURODESIS; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

ANOXEMIA; BLOOD GAS ANALYSIS; FEVER; HUMANS; LUNG; OXYGEN; PARTIAL PRESSURE; PARTICLE SIZE; PLEURAL EFFUSION; PLEURODESIS; PNEUMONIA; PROSPECTIVE STUDIES; TALC;

EID: 4544362255     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200311-1579OC     Document Type: Article

References (24)

1. Dresler CM. Systemic distribution of talc. Chest 1999;116:266.
2. Kennedy L, Rusch VW, Strange C, Ginsberg RJ, Sahn SA. Pleurodesis using talc slurry. Chest 1994;106:342-346.
3. Weissberg D, Ben Zeev I. Talc pleurodesis: experience with 360 patients. J Thorac Cardiovasc Surg 1993;105:689-695.
4. Webb WR, Ozmen V, Moulder PV, Shabahang B, Breaux J. Iodized talc pleurodesis for the treatment of pleural effusions. J Thorac Cardiovasc Surg 1992;103:881-885.
5. Brant A, Eaton T. Serious complications with talc slurry pleurodesis. Respirology 2001;6:181-185.
6. Rinaldo JE, Owens GR, Rogers RM. Adult respiratory distress syndrome following intrapleural instillation of talc. J Thorac Cardiovasc Surg 1983;85:523-526.
7. Bouchama A, Chastre J, Gaudichet A. Soler P, Gibert C. Acute pneumonitis with bilateral pleural effusion after talc pleurodesis. Chest 1984;86:795-797.
8. Rehse DH, Aye RW. Florence MG. Respiratory failure following talc pleurodesis. Am J Surg 1999;177:437-440.
9. Migueres J, Jover A. Indications for intrapleural talc under pleuroscopic control in malignant recurrent pleural effusions: based on 26 cases. Poumon Coeur 1981;37:295-297.
10. Marel M, Skacel Z, Bednar M, Julak J, Light RW. Corynebacterium parvum, bleomycin and talc in the treatment of malignant pleural effusions. J Bon 1998;1:165-170.
11. Campos JR, Werebe EC, Vargas FS, Jatene FB, Light RW. Respiratory failure due to insufflated talc. Lancet 1997;349:251-252.
12. Todd TR, Delarue NC, Ilves R, Pearson FG, Cooper JD. Talc poudrage for malignant pleural effusions. Chest 1980;77:493-495.
13. Nandi P. Recurrent spontaneous pneumothorax: an effective method of talc poudrage. Chest 1980;77:493-495.
14. Lee YCG, Baumann MH, Maskell NA, Waterer GW, Davies RJO, Heffner J, Light RW. Survey of pulmonologists on pleurodesis practice for malignant pleural effusions in five English speaking countries. Chest 2003;124:2229-2238.
15. Rodriguez-Panadero F, Antony VB. Pleurodesis: state of the art. Eur Respir J 1997;10:1648-1654.
16. Watanabe N, Inoue T, Oriuchi N, Suzuki H, Hirano T, Endo K. Increased pulmonary clearance of aerosolized 99Tcm-DTPA in patients with a subset of stage I sarcoidosis. Nucl Med Commun 1995;16:464-467.
17. Susskind H, Weber DA, Lau YH, Park TL, Atkins HL, Franceschi D, Meek AG, Ivanovic M, Wielopolski L. Impaired permeability in radiation-induced lung injury detected by technetium-99m-DTPA lung clearance. J Nucl Med 1997;38:966-971.
18. Labrune S, Chinet T, Collignon MA, Barritault L, Huchon GJ. Mechanisms of increased epithelial lung clearance of DTPA in diffuse fibrosing alveolitis. Eur Respir J 1994;7:651-656.
19. Sundram FX. Clinical studies of alveolar-capillary permeability using technetium-99m DTPA aerosol. Ann Nucl Med 1995;9:171-178.
20. Maskell NA, Gleeson F, Jones E, Davies RJO. Talc but not tetracycline pleurodesis induces hypoxaemia and increased DTPA clearance from the contra-lateral lung. Am J Respir Crit Care Med 2002;165:B11.
21. Ferrer J, Montes JF, Villarino MA, Light RW, Garcia-Valero J. Influence of particle size on extrapleural talc dissemination after talc slurry pleurodesis. Chest 2002;122:1018-1027.
22. Kennedy L, Harley RA, Sahn SA, Strange C. Talc slurry pleurodesis: pleural fluid and histologic analysis. Chest 1995;107:1707-1712.
23. Werebe EC, Pazetti R, Milanez C Jr, Fernandez PP, Capelozzi VL, Jatene FB, Fargas FS. Systemic distribution of talc after intrapleural administration in rats. Chest 1999;115:190-193.
24. Montes JF, Ferrer J, Villarino MA, Baeza B, Crespo M, Garcia-Valero J. Influence of talc dose on extrapleural talc dissemination after talc pleurodesis. Am J Respir Crit Care Med 2003;168:348-355.